[
  {
    "title": "A股异动 | 济川药业涨4.3% 年产7.2亿袋小儿豉翘清热颗粒项目正进行净化工程安装",
    "href": "http://stock.jrj.com.cn/2023/01/03112137254534.shtml",
    "datetime": "2023-01-03 11:21:47",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：“年产7.2亿袋小儿豉翘清热颗粒项目”正在进行净化工程安装",
    "href": "http://stock.jrj.com.cn/2023/01/02170037253199.shtml",
    "datetime": "2023-01-02 17:00:14",
    "code": "600566"
  },
  {
    "title": "济川药业：全资子公司产品退出省级医保目录",
    "href": "http://stock.jrj.com.cn/2022/12/28165137243379.shtml",
    "datetime": "2022-12-28 16:51:23",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：济川有限雷贝拉唑钠肠溶片获批上市",
    "href": "http://stock.jrj.com.cn/2022/11/22171337157851.shtml",
    "datetime": "2022-11-22 17:13:04",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)与恒翼生物医药签署独家合作协议",
    "href": "http://stock.jrj.com.cn/2022/11/06155637115190.shtml",
    "datetime": "2022-11-06 15:56:59",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：“济川转债”预计满足赎回条件暨不行使提前赎回权",
    "href": "http://stock.jrj.com.cn/2022/11/01170837103656.shtml",
    "datetime": "2022-11-01 17:08:21",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)三季度净利5.77亿元 同比增长37.89%",
    "href": "http://stock.jrj.com.cn/2022/10/23161037075701.shtml",
    "datetime": "2022-10-23 16:10:06",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：财务总监变更为严宏泉",
    "href": "http://stock.jrj.com.cn/2022/09/26173237022107.shtml",
    "datetime": "2022-09-26 17:32:09",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：向激励对象授予607.4万股限制性股票、651.4万份股票期权",
    "href": "http://stock.jrj.com.cn/2022/09/08174236983796.shtml",
    "datetime": "2022-09-08 17:42:49",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)： 获得七味刺榆颗粒《药品注册备案通知书》",
    "href": "http://stock.jrj.com.cn/2022/09/01183036963784.shtml",
    "datetime": "2022-09-01 18:30:12",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：上半年净利润增18.94%至10.16亿元",
    "href": "http://stock.jrj.com.cn/2022/08/19175636916948.shtml",
    "datetime": "2022-08-19 17:56:08",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：东科制药的孟鲁司特钠颗粒获批上市",
    "href": "http://stock.jrj.com.cn/2022/08/08170436879330.shtml",
    "datetime": "2022-08-08 17:04:28",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：拟推1574.2万股的2022年限制性股票与股票期权激励计划",
    "href": "http://stock.jrj.com.cn/2022/08/01192136860325.shtml",
    "datetime": "2022-08-01 19:21:03",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)半年度预盈10亿元、同比增长20%",
    "href": "http://stock.jrj.com.cn/2022/07/21190536832935.shtml",
    "datetime": "2022-07-21 19:05:43",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：济川有限的蒲地蓝消炎口服液、蛋白琥珀酸铁口服溶液将退出省级医保目录",
    "href": "http://stock.jrj.com.cn/2022/06/28161636764518.shtml",
    "datetime": "2022-06-28 16:16:01",
    "code": "600566"
  },
  {
    "title": "济川药业副总经理刘俊辞职 2021年薪酬为265万",
    "href": "http://stock.jrj.com.cn/2022/06/17213136739529.shtml",
    "datetime": "2022-06-17 21:31:58",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：2021年度权益分派10派6.8元 股权登记日为5月25日",
    "href": "http://stock.jrj.com.cn/2022/05/18174536659354.shtml",
    "datetime": "2022-05-18 17:45:07",
    "code": "600566"
  },
  {
    "title": "济川药业2022年第一季度净利5.81亿同比增长32.36% 销售业绩增长",
    "href": "http://stock.jrj.com.cn/2022/04/23161236437220.shtml",
    "datetime": "2022-04-23 16:12:31",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)一季度净利润5.81亿元 同比增长32.36%",
    "href": "http://stock.jrj.com.cn/2022/04/22155436428614.shtml",
    "datetime": "2022-04-22 15:54:12",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：济川有限拟出资3000万元认购新建元四期的基金份额",
    "href": "http://stock.jrj.com.cn/2022/04/20180236411185.shtml",
    "datetime": "2022-04-20 18:02:35",
    "code": "600566"
  },
  {
    "title": "济川药业2021年净利17.19亿同比增长34.60% 董事长曹龙祥薪酬240.40万",
    "href": "http://stock.jrj.com.cn/2022/04/16123036351835.shtml",
    "datetime": "2022-04-16 12:30:55",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：严宏泉辞任财务总监 潘留焱接任",
    "href": "http://stock.jrj.com.cn/2022/04/15200436346799.shtml",
    "datetime": "2022-04-15 20:04:46",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：2021年度净利升34.60%至17.19亿元 拟10派6.8元",
    "href": "http://stock.jrj.com.cn/2022/04/15195136346777.shtml",
    "datetime": "2022-04-15 19:51:19",
    "code": "600566"
  },
  {
    "title": "A股异动 | 济川药业(600566.SH)涨6% 前两月净利同比增长35%",
    "href": "http://stock.jrj.com.cn/2022/03/11094934812515.shtml",
    "datetime": "2022-03-11 09:49:34",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：1-2月实现净利润4.7亿元左右 同比增长约35%",
    "href": "http://stock.jrj.com.cn/2022/03/10160134808785.shtml",
    "datetime": "2022-03-10 16:01:28",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：济川医学获得高新技术企业证书",
    "href": "http://stock.jrj.com.cn/2022/03/01161434508172.shtml",
    "datetime": "2022-03-01 16:14:01",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：硫酸镁钠钾口服用浓溶液获批上市",
    "href": "http://stock.jrj.com.cn/2022/02/10180634318954.shtml",
    "datetime": "2022-02-10 18:06:14",
    "code": "600566"
  },
  {
    "title": "济川药业2021年净利16.64亿同比增长30.31% 医疗机构逐步恢复正常运行",
    "href": "http://stock.jrj.com.cn/2022/01/19191234175182.shtml",
    "datetime": "2022-01-19 19:12:05",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)业绩快报：2021年度归母净利增30.31%至16.64亿元",
    "href": "http://stock.jrj.com.cn/2022/01/19162534174234.shtml",
    "datetime": "2022-01-19 16:25:45",
    "code": "600566"
  },
  {
    "title": "【龙虎榜】济川药业1月4日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/04180934121833.shtml",
    "datetime": "2022-01-04 18:09:12",
    "code": "600566"
  },
  {
    "title": "【龙虎榜】济川药业11月12日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/11/12180733841889.shtml",
    "datetime": "2021-11-12 18:07:13",
    "code": "600566"
  },
  {
    "title": "济川药业：伊坦生长激素能否成功获批上市存在一定风险",
    "href": "http://stock.jrj.com.cn/2021/11/12171633841551.shtml",
    "datetime": "2021-11-12 17:16:57",
    "code": "600566"
  },
  {
    "title": "二连板济川药业：伊坦生长激素能否成功获批上市存在一定风险",
    "href": "http://stock.jrj.com.cn/2021/11/12164233841273.shtml",
    "datetime": "2021-11-12 16:42:15",
    "code": "600566"
  },
  {
    "title": "【龙虎榜】济川药业11月11日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/11/11180933837184.shtml",
    "datetime": "2021-11-11 18:09:04",
    "code": "600566"
  },
  {
    "title": "A股异动 | 济川药业(600566.SH)一字涨停 与天境生物就生长激素达成战略合作",
    "href": "http://stock.jrj.com.cn/2021/11/11094333835070.shtml",
    "datetime": "2021-11-11 09:43:08",
    "code": "600566"
  },
  {
    "title": "济川药业一字涨停 拟20亿元进军伊坦生长激素",
    "href": "http://stock.jrj.com.cn/2021/11/11093433835011.shtml",
    "datetime": "2021-11-11 09:34:07",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：子公司签署伊坦生长激素(TJ101)独家开发、生产及销售合作协议",
    "href": "http://stock.jrj.com.cn/2021/11/10164933832021.shtml",
    "datetime": "2021-11-10 16:49:59",
    "code": "600566"
  },
  {
    "title": "A股异动 | 济川药业涨停 第三季净利同比增52.16%",
    "href": "http://stock.jrj.com.cn/2021/11/01094533795546.shtml",
    "datetime": "2021-11-01 09:45:25",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：第三季度净利增52.16%至4.18亿元",
    "href": "http://stock.jrj.com.cn/2021/10/29192333779276.shtml",
    "datetime": "2021-10-29 19:23:13",
    "code": "600566"
  },
  {
    "title": "同一种规格的这种儿童药，口味不同，价格差近一倍！济川药业被暂停采购",
    "href": "http://stock.jrj.com.cn/2021/10/23082033737288.shtml",
    "datetime": "2021-10-23 08:20:26",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：子公司拟出资3000万元参与认购泰福怀谨",
    "href": "http://stock.jrj.com.cn/2021/09/30164133543399.shtml",
    "datetime": "2021-09-30 16:41:49",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：蒲地蓝消炎口服液将于2022年退出新疆省级医保目录",
    "href": "http://stock.jrj.com.cn/2021/09/10180633416167.shtml",
    "datetime": "2021-09-10 18:06:14",
    "code": "600566"
  },
  {
    "title": "A股异动 | 济川药业(600566.SH)涨超8% 上半年净利同比增24.7%",
    "href": "http://stock.jrj.com.cn/2021/08/23113233301720.shtml",
    "datetime": "2021-08-23 11:32:14",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：上半年净利增24.70%至8.54亿元",
    "href": "http://stock.jrj.com.cn/2021/08/20213033289538.shtml",
    "datetime": "2021-08-20 21:30:59",
    "code": "600566"
  },
  {
    "title": "济川药业2021年半年度净利8.54亿元 同比净利增加24.70%",
    "href": "http://stock.jrj.com.cn/2021/08/20211033289435.shtml",
    "datetime": "2021-08-20 21:10:09",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：子公司产品蒲地蓝消炎口服液将退出黑龙江省医保目录",
    "href": "http://stock.jrj.com.cn/2021/08/18205533275836.shtml",
    "datetime": "2021-08-18 20:55:49",
    "code": "600566"
  },
  {
    "title": "拳头产品蒲地蓝口服液遭两省医保清退，济川药业业绩下滑后进军日化领域",
    "href": "http://stock.jrj.com.cn/2021/08/12062333240154.shtml",
    "datetime": "2021-08-12 06:23:55",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：子公司产品蒲地蓝消炎口服液退出省级医保目录",
    "href": "http://stock.jrj.com.cn/2021/08/10162333231855.shtml",
    "datetime": "2021-08-10 16:23:28",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：放弃蒲地蓝日化的增资优先认购权",
    "href": "http://stock.jrj.com.cn/2021/08/01125233180428.shtml",
    "datetime": "2021-08-01 12:52:10",
    "code": "600566"
  },
  {
    "title": "济川药业：为提升资产运作水平 子公司拟3000万元参与认购基金份额",
    "href": "http://stock.jrj.com.cn/2021/07/20185533125639.shtml",
    "datetime": "2021-07-20 18:55:12",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：拟参与认购博远厚诚二期的出资份额3000万元",
    "href": "http://stock.jrj.com.cn/2021/07/20162233124517.shtml",
    "datetime": "2021-07-20 16:22:36",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：全资子公司2款药品退出河北省医保目录",
    "href": "http://stock.jrj.com.cn/2021/07/06163333053280.shtml",
    "datetime": "2021-07-06 16:33:09",
    "code": "600566"
  },
  {
    "title": "济川药业：目前蒲地蓝消炎口服液仍在部分省份的医保目录中",
    "href": "http://stock.jrj.com.cn/2021/06/24194832991228.shtml",
    "datetime": "2021-06-24 19:48:49",
    "code": "600566"
  },
  {
    "title": "济川药业：公司目前生产经营情况正常",
    "href": "http://stock.jrj.com.cn/2021/06/24194732991209.shtml",
    "datetime": "2021-06-24 19:47:20",
    "code": "600566"
  },
  {
    "title": "济川药业：公司已在开展改善小儿豉翘清热颗粒口感的工作",
    "href": "http://stock.jrj.com.cn/2021/06/11210132913913.shtml",
    "datetime": "2021-06-11 21:01:52",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)2020年度拟10派4.5元 股权登记日5月25日",
    "href": "http://stock.jrj.com.cn/2021/05/19174632782385.shtml",
    "datetime": "2021-05-19 17:46:59",
    "code": "600566"
  },
  {
    "title": "济川药业：2020年末公司应收账款中96%以上均为1年以内应收账款",
    "href": "http://stock.jrj.com.cn/2021/05/10115932727993.shtml",
    "datetime": "2021-05-10 11:59:15",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：约7332.99万股限售股4月26日解禁",
    "href": "http://stock.jrj.com.cn/2021/04/20181632411118.shtml",
    "datetime": "2021-04-20 18:16:18",
    "code": "600566"
  },
  {
    "title": "济川药业2021年第一季度净利下滑5.4% 研发费用增加",
    "href": "http://stock.jrj.com.cn/2021/04/18101532392652.shtml",
    "datetime": "2021-04-18 10:15:15",
    "code": "600566"
  },
  {
    "title": "济川药业2020年净利下滑21.3% 董事长曹龙祥薪酬300.41万",
    "href": "http://stock.jrj.com.cn/2021/04/18100432392622.shtml",
    "datetime": "2021-04-18 10:04:37",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)一季度净利润降5.4%至4.39亿元",
    "href": "http://stock.jrj.com.cn/2021/04/16183832387932.shtml",
    "datetime": "2021-04-16 18:38:33",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：2020年度净利降21.3%至12.77亿元 拟10派4.5元",
    "href": "http://stock.jrj.com.cn/2021/04/16183632387925.shtml",
    "datetime": "2021-04-16 18:36:43",
    "code": "600566"
  },
  {
    "title": "济川药业：公司对已开拓的渠道资源进行了梳理继续加强空白地区市场的开发",
    "href": "http://stock.jrj.com.cn/2021/04/08132732331455.shtml",
    "datetime": "2021-04-08 13:27:22",
    "code": "600566"
  },
  {
    "title": "济川药业：2019年末公司应收账款中95%以上均为1年以内应收账款",
    "href": "http://stock.jrj.com.cn/2021/03/25151732215634.shtml",
    "datetime": "2021-03-25 15:17:46",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：宫瘤清片获药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2021/02/28155432039762.shtml",
    "datetime": "2021-02-28 15:54:37",
    "code": "600566"
  },
  {
    "title": "济川药业：目前公司产品在电商渠道销售收入占公司营业收入的比例很小公司已组建电商团队",
    "href": "http://stock.jrj.com.cn/2021/02/26161032033168.shtml",
    "datetime": "2021-02-26 16:10:50",
    "code": "600566"
  },
  {
    "title": "济川药业：公司使用暂时闲置的募集资金购买金融机构的保本型理财产品提高闲置募集资金使用效率",
    "href": "http://stock.jrj.com.cn/2021/01/22090731742604.shtml",
    "datetime": "2021-01-22 09:07:19",
    "code": "600566"
  },
  {
    "title": "济川药业：目前蒲地蓝消炎口服液仅在国内销售",
    "href": "http://stock.jrj.com.cn/2021/01/22090631742511.shtml",
    "datetime": "2021-01-22 09:06:17",
    "code": "600566"
  },
  {
    "title": "[济川药业]蒲地蓝消炎口服液品牌建设新突破",
    "href": "http://stock.jrj.com.cn/2021/01/09000031698883.shtml",
    "datetime": "2021-01-09 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]汇双百韬略 立奋进潮头 争创新发展 ——济川药业隆重召开2021年年会",
    "href": "http://stock.jrj.com.cn/2021/01/07000031649318.shtml",
    "datetime": "2021-01-07 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]济川药业喜获4项殊荣",
    "href": "http://stock.jrj.com.cn/2021/01/06000031649317.shtml",
    "datetime": "2021-01-06 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]表扬通报!全国工商联为济川药业战役情点赞",
    "href": "http://stock.jrj.com.cn/2020/12/30000031605994.shtml",
    "datetime": "2020-12-30 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]济川药业再添3个国家医保产品",
    "href": "http://stock.jrj.com.cn/2020/12/29000031595022.shtml",
    "datetime": "2020-12-29 00:00:00",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：子公司3个药品进入国家医保目录",
    "href": "http://stock.jrj.com.cn/2020/12/28180631587330.shtml",
    "datetime": "2020-12-28 18:06:41",
    "code": "600566"
  },
  {
    "title": "[济川药业]济川蒲地蓝和同贝 入选《中成药治疗小儿急性上呼吸道感染感染指南》",
    "href": "http://stock.jrj.com.cn/2020/12/28000031595024.shtml",
    "datetime": "2020-12-28 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]黄龙止咳颗粒最新研究成果来了",
    "href": "http://stock.jrj.com.cn/2020/12/26000031605995.shtml",
    "datetime": "2020-12-26 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]蒲地蓝消炎口服液皮肤领域结新果",
    "href": "http://stock.jrj.com.cn/2020/12/21000031537802.shtml",
    "datetime": "2020-12-21 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]济川药业荣获第五届“江苏慈善奖”",
    "href": "http://stock.jrj.com.cn/2020/12/11000031464484.shtml",
    "datetime": "2020-12-11 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]围观!济川蒲地蓝与济诺闪耀2020“中国医药·品牌榜”",
    "href": "http://stock.jrj.com.cn/2020/12/10000031464482.shtml",
    "datetime": "2020-12-10 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]济川药业消化领域添新品! 琥珀酸普芦卡必利片获《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2020/12/09000031464487.shtml",
    "datetime": "2020-12-09 00:00:00",
    "code": "600566"
  },
  {
    "title": "济川药业：下属全资子公司琥珀酸普芦卡必利片获《药品注册证书》",
    "href": "http://stock.jrj.com.cn/2020/12/07184031432230.shtml",
    "datetime": "2020-12-07 18:40:01",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：子公司琥珀酸普芦卡必利片获得药品注册证书",
    "href": "http://stock.jrj.com.cn/2020/12/07180431431898.shtml",
    "datetime": "2020-12-07 18:04:18",
    "code": "600566"
  },
  {
    "title": "[济川药业]第一届环渤海妇产科学术论坛在泰兴举行",
    "href": "http://stock.jrj.com.cn/2020/12/07000031430710.shtml",
    "datetime": "2020-12-07 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]《现代医院》第五届编委会在济川药业成功召开",
    "href": "http://stock.jrj.com.cn/2020/12/05000031428928.shtml",
    "datetime": "2020-12-05 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]刚刚!济川药业三个大品种上榜中国药店店员推荐率最高品牌",
    "href": "http://stock.jrj.com.cn/2020/12/05000031428927.shtml",
    "datetime": "2020-12-05 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]济川药业9个产品荣获江苏省医药行业优秀产品品牌",
    "href": "http://stock.jrj.com.cn/2020/11/23000031358799.shtml",
    "datetime": "2020-11-23 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]重磅!院士点赞甘海胃康胶囊治疗慢性胃炎研究成果",
    "href": "http://stock.jrj.com.cn/2020/11/20000031358801.shtml",
    "datetime": "2020-11-20 00:00:00",
    "code": "600566"
  },
  {
    "title": "[济川药业]济川药业荣获全国“安康杯”竞赛优胜单位奖",
    "href": "http://stock.jrj.com.cn/2020/11/19000031358798.shtml",
    "datetime": "2020-11-19 00:00:00",
    "code": "600566"
  },
  {
    "title": "济川药业前三季度净利9.6亿减少26.5% 理财产品投资收益及政府补助减少",
    "href": "http://stock.jrj.com.cn/2020/10/26074131130492.shtml",
    "datetime": "2020-10-26 07:41:00",
    "code": "600566"
  },
  {
    "title": "济川药业：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/24001131119771.shtml",
    "datetime": "2020-10-24 00:11:18",
    "code": "600566"
  },
  {
    "title": "济川药业：召开2020年第二次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/10/24001131119770.shtml",
    "datetime": "2020-10-24 00:11:17",
    "code": "600566"
  },
  {
    "title": "济川药业：第九届董事会第六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/10/24001131119769.shtml",
    "datetime": "2020-10-24 00:11:16",
    "code": "600566"
  },
  {
    "title": "济川药业：第九届董事会第五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/10/13001031035263.shtml",
    "datetime": "2020-10-13 00:10:39",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：拟使用银行承兑汇票支付募投项目并以募集资金等额置换",
    "href": "http://stock.jrj.com.cn/2020/10/12181331033121.shtml",
    "datetime": "2020-10-12 18:13:00",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：拟使用募集资金向全资子公司济川有限、济川医学及东科制药增资",
    "href": "http://stock.jrj.com.cn/2020/10/12180931033125.shtml",
    "datetime": "2020-10-12 18:09:26",
    "code": "600566"
  },
  {
    "title": "济川药业(600566.SH)：共有约2.12亿元“济川转债”已转换成公司股票",
    "href": "http://stock.jrj.com.cn/2020/10/10123131015550.shtml",
    "datetime": "2020-10-10 12:31:59",
    "code": "600566"
  },
  {
    "title": "济川药业2020年上半年净利6.85亿下滑28.94% 主要产品销售收入下降",
    "href": "http://stock.jrj.com.cn/2020/08/22082830562170.shtml",
    "datetime": "2020-08-22 08:28:45",
    "code": "600566"
  },
  {
    "title": "济川药业2020年上半年净利6.85亿下滑28.94% 门诊量下降幅度较大",
    "href": "http://stock.jrj.com.cn/2020/07/22203030316848.shtml",
    "datetime": "2020-07-22 20:30:49",
    "code": "600566"
  },
  {
    "title": "济川药业非公开发行股票申请获审核通过",
    "href": "http://stock.jrj.com.cn/2020/07/03202830136419.shtml",
    "datetime": "2020-07-03 20:28:24",
    "code": "600566"
  },
  {
    "title": "1药网与济川药业达成战略合作",
    "href": "http://stock.jrj.com.cn/2020/06/15172529928724.shtml",
    "datetime": "2020-06-15 17:25:00",
    "code": "600566"
  },
  {
    "title": "济川药业第一季度盈利4.64亿同比减少9.02% 理财产品减少",
    "href": "http://stock.jrj.com.cn/2020/04/25131629374134.shtml",
    "datetime": "2020-04-25 13:16:25",
    "code": "600566"
  },
  {
    "title": "济川药业：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/25051029371725.shtml",
    "datetime": "2020-04-25 05:10:03",
    "code": "600566"
  },
  {
    "title": "济川药业：关于实施权益分派时“济川转债”转股连续停牌的提示性公告",
    "href": "http://stock.jrj.com.cn/2020/04/10231029260185.shtml",
    "datetime": "2020-04-10 23:10:02",
    "code": "600566"
  },
  {
    "title": "济川药业：2019年蒲地蓝少卖4000万盒 销售人均差旅17万元",
    "href": "http://stock.jrj.com.cn/2020/04/06093029208869.shtml",
    "datetime": "2020-04-06 09:30:53",
    "code": "600566"
  },
  {
    "title": "济川药业：2019年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/03011029180462.shtml",
    "datetime": "2020-04-03 01:10:06",
    "code": "600566"
  },
  {
    "title": "济川药业：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/03/13003029012937.shtml",
    "datetime": "2020-03-13 00:30:05",
    "code": "600566"
  },
  {
    "title": "济川药业：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/03/13003029012936.shtml",
    "datetime": "2020-03-13 00:30:05",
    "code": "600566"
  },
  {
    "title": "济川药业：第九届董事会第二次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/13003029012935.shtml",
    "datetime": "2020-03-13 00:30:04",
    "code": "600566"
  },
  {
    "title": "济川药业：2019年净利同比降3.84% 拟10派12.3元",
    "href": "http://stock.jrj.com.cn/2020/03/12200929011837.shtml",
    "datetime": "2020-03-12 20:09:00",
    "code": "600566"
  },
  {
    "title": "济川药业：2019年度净利同比下降3.84% 拟10派12.3元",
    "href": "http://stock.jrj.com.cn/2020/03/12195029011729.shtml",
    "datetime": "2020-03-12 19:50:16",
    "code": "600566"
  },
  {
    "title": "济川药业：第九届董事会第一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/02231028937191.shtml",
    "datetime": "2020-03-02 23:10:12",
    "code": "600566"
  },
  {
    "title": "济川药业：2020年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/03/02231028937190.shtml",
    "datetime": "2020-03-02 23:10:12",
    "code": "600566"
  },
  {
    "title": "济川药业：下修可转换债券转股价格",
    "href": "http://stock.jrj.com.cn/2020/03/02193228935901.shtml",
    "datetime": "2020-03-02 19:32:39",
    "code": "600566"
  },
  {
    "title": "济川药业：向下修正可转换债券转股价格",
    "href": "http://stock.jrj.com.cn/2020/03/02184028935682.shtml",
    "datetime": "2020-03-02 18:40:00",
    "code": "600566"
  },
  {
    "title": "济川药业：关于召开2020年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/02/14212028831485.shtml",
    "datetime": "2020-02-14 21:20:00",
    "code": "600566"
  },
  {
    "title": "济川药业：第八届董事会第二十次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/02/14212028831484.shtml",
    "datetime": "2020-02-14 21:20:00",
    "code": "600566"
  },
  {
    "title": "济川药业向武汉红十字会捐赠千万元急需药品和防护物资",
    "href": "http://stock.jrj.com.cn/2020/01/27131828737599.shtml",
    "datetime": "2020-01-27 13:18:00",
    "code": "600566"
  },
  {
    "title": "济川药业左乙拉西坦注射用浓溶液获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/01/13181628669023.shtml",
    "datetime": "2020-01-13 18:16:38",
    "code": "600566"
  },
  {
    "title": "济川药业：子公司获左乙拉西坦注射用浓溶液《药品注册批件》",
    "href": "http://stock.jrj.com.cn/2020/01/13173928668125.shtml",
    "datetime": "2020-01-13 17:39:33",
    "code": "600566"
  },
  {
    "title": "济川药业：第八届董事会第十九次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/12/21004028565161.shtml",
    "datetime": "2019-12-21 00:40:20",
    "code": "600566"
  },
  {
    "title": "济川药业聘任曹飞担任总经理",
    "href": "http://stock.jrj.com.cn/2019/12/20224428564771.shtml",
    "datetime": "2019-12-20 22:44:02",
    "code": "600566"
  },
  {
    "title": "济川药业：子公司认购基金份额 投资创新生物医药等领域",
    "href": "http://stock.jrj.com.cn/2019/12/03162328483605.shtml",
    "datetime": "2019-12-03 16:23:00",
    "code": "600566"
  },
  {
    "title": "济川药业：关于“济川转债”2019年付息事宜的公告",
    "href": "http://stock.jrj.com.cn/2019/11/06235028362343.shtml",
    "datetime": "2019-11-06 23:50:00",
    "code": "600566"
  },
  {
    "title": "济川药业前三季度盈利13.06亿 同比下滑0.24%",
    "href": "http://stock.jrj.com.cn/2019/10/26083828303440.shtml",
    "datetime": "2019-10-26 08:38:04",
    "code": "600566"
  },
  {
    "title": "济川药业：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/23222028025499.shtml",
    "datetime": "2019-08-23 22:20:16",
    "code": "600566"
  },
  {
    "title": "济川药业：第八届董事会第十七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/23222028025498.shtml",
    "datetime": "2019-08-23 22:20:16",
    "code": "600566"
  },
  {
    "title": "济川药业2019年上半年净利9.64亿 中药口服液智能化车间正式投产",
    "href": "http://stock.jrj.com.cn/2019/08/23182328024323.shtml",
    "datetime": "2019-08-23 18:23:59",
    "code": "600566"
  },
  {
    "title": "济川药业：上半年净利9.64亿元 同比增长14%",
    "href": "http://stock.jrj.com.cn/2019/08/23173628023709.shtml",
    "datetime": "2019-08-23 17:36:40",
    "code": "600566"
  },
  {
    "title": "济川药业：上半年净利同比增长14.38%",
    "href": "http://stock.jrj.com.cn/2019/08/23171428023536.shtml",
    "datetime": "2019-08-23 17:14:00",
    "code": "600566"
  },
  {
    "title": "济川药业：2018年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/05/26193027623684.shtml",
    "datetime": "2019-05-26 19:30:00",
    "code": "600566"
  },
  {
    "title": "济川药业：2018年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/05/13220027565586.shtml",
    "datetime": "2019-05-13 22:00:09",
    "code": "600566"
  },
  {
    "title": "济川药业2019年一季度净利5.10亿元 董事长曹龙祥持股4684万股",
    "href": "http://stock.jrj.com.cn/2019/04/21132427450713.shtml",
    "datetime": "2019-04-21 13:24:08",
    "code": "600566"
  },
  {
    "title": "济川药业去年净利16.88亿同比增长38% 董事长曹龙祥年薪200万元",
    "href": "http://stock.jrj.com.cn/2019/04/20181827434684.shtml",
    "datetime": "2019-04-20 18:18:12",
    "code": "600566"
  },
  {
    "title": "济川药业：2018年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/20002027431294.shtml",
    "datetime": "2019-04-20 00:20:06",
    "code": "600566"
  },
  {
    "title": "济川药业：2019年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/04/20002027431293.shtml",
    "datetime": "2019-04-20 00:20:06",
    "code": "600566"
  },
  {
    "title": "济川药业：第八届董事会第十六次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/04/20002027431295.shtml",
    "datetime": "2019-04-20 00:20:06",
    "code": "600566"
  },
  {
    "title": "济川药业：关于召开2018年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/04/20002027431296.shtml",
    "datetime": "2019-04-20 00:20:06",
    "code": "600566"
  },
  {
    "title": "济川药业：2018年净利同比增37.96% 拟10派12.3元",
    "href": "http://stock.jrj.com.cn/2019/04/19185827429864.shtml",
    "datetime": "2019-04-19 18:58:45",
    "code": "600566"
  },
  {
    "title": "济川药业2018年净利增长38% 拟10派12.3元",
    "href": "http://stock.jrj.com.cn/2019/04/19172727429409.shtml",
    "datetime": "2019-04-19 17:27:30",
    "code": "600566"
  },
  {
    "title": "济川药业：2018年净盈利16.9亿元 拟10派12.3元",
    "href": "http://stock.jrj.com.cn/2019/04/19162327429023.shtml",
    "datetime": "2019-04-19 16:23:23",
    "code": "600566"
  },
  {
    "title": "[互动]济川药业：研发费用率与行业平均水平相当",
    "href": "http://stock.jrj.com.cn/2019/03/15143427173113.shtml",
    "datetime": "2019-03-15 14:34:37",
    "code": "600566"
  },
  {
    "title": "济川药业：第八届董事会第十五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/02/27214027098857.shtml",
    "datetime": "2019-02-27 21:40:06",
    "code": "600566"
  },
  {
    "title": "医药板块结束三连跌 券商力荐7只超跌高成长股",
    "href": "http://stock.jrj.com.cn/2018/12/12005025590527.shtml",
    "datetime": "2018-12-12 00:50:17",
    "code": "600566"
  },
  {
    "title": "明星药“蒲地蓝”儿童慎用引发这只牛股济川药业闪崩",
    "href": "http://stock.jrj.com.cn/2018/11/08065825316963.shtml",
    "datetime": "2018-11-08 06:58:18",
    "code": "600566"
  },
  {
    "title": "济川药业：关于“济川转债”2018年付息事宜的公告",
    "href": "http://stock.jrj.com.cn/2018/11/06211025311984.shtml",
    "datetime": "2018-11-06 21:10:00",
    "code": "600566"
  },
  {
    "title": "济川药业：2018年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/10/19215025230021.shtml",
    "datetime": "2018-10-19 21:50:01",
    "code": "600566"
  },
  {
    "title": "济川药业：第八届董事会第十四次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/10/19215025230022.shtml",
    "datetime": "2018-10-19 21:50:01",
    "code": "600566"
  },
  {
    "title": "济川药业：2018年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/10/08222025171472.shtml",
    "datetime": "2018-10-08 22:20:00",
    "code": "600566"
  },
  {
    "title": "济川药业：关于召开2018年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/09/17213025102730.shtml",
    "datetime": "2018-09-17 21:30:04",
    "code": "600566"
  },
  {
    "title": "济川药业：第八届董事会第十三次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/09/17213025102729.shtml",
    "datetime": "2018-09-17 21:30:04",
    "code": "600566"
  },
  {
    "title": "济川药业：子公司通过GMP认证",
    "href": "http://stock.jrj.com.cn/hotstock/2018/08/02075924893704.shtml",
    "datetime": "2018-08-02 07:59:56",
    "code": "600566"
  },
  {
    "title": "济川药业中报:高增长中的三点隐忧 销售费用居高不下",
    "href": "http://stock.jrj.com.cn/2018/08/02075924893632.shtml",
    "datetime": "2018-08-02 07:59:47",
    "code": "600566"
  },
  {
    "title": "济川药业：业绩略超预期，OTC扩张成效显著",
    "href": "http://stock.jrj.com.cn/2018/07/31142424884675.shtml",
    "datetime": "2018-07-31 14:24:00",
    "code": "600566"
  },
  {
    "title": "济川药业：2018年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/07/27220024873770.shtml",
    "datetime": "2018-07-27 22:00:15",
    "code": "600566"
  },
  {
    "title": "济川药业：第八届董事会第十二次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/07/27220024873771.shtml",
    "datetime": "2018-07-27 22:00:15",
    "code": "600566"
  },
  {
    "title": "济川药业：上半年盈利8.43亿元 同比增44.8%",
    "href": "http://stock.jrj.com.cn/2018/07/27210024873580.shtml",
    "datetime": "2018-07-27 21:00:00",
    "code": "600566"
  },
  {
    "title": "济川药业股东拟减持不超过1222万股 占比1.5%",
    "href": "http://stock.jrj.com.cn/2018/07/27205624873558.shtml",
    "datetime": "2018-07-27 20:56:22",
    "code": "600566"
  },
  {
    "title": "济川药业：三产品进入湖南省药品整合目录",
    "href": "http://stock.jrj.com.cn/hotstock/2018/07/23152424850988.shtml",
    "datetime": "2018-07-23 15:24:32",
    "code": "600566"
  },
  {
    "title": "济川药业：三产品进入湖南省药品整合目录",
    "href": "http://stock.jrj.com.cn/2018/07/20211024844650.shtml",
    "datetime": "2018-07-20 21:10:00",
    "code": "600566"
  },
  {
    "title": "济川药业部分产品进、退2018年辽宁医保目录",
    "href": "http://stock.jrj.com.cn/2018/06/15175524687028.shtml",
    "datetime": "2018-06-15 17:55:06",
    "code": "600566"
  },
  {
    "title": "济川药业：2017年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2018/05/24222024587488.shtml",
    "datetime": "2018-05-24 22:20:00",
    "code": "600566"
  },
  {
    "title": "济川药业年报推10派10元 股权登记5月31日",
    "href": "http://stock.jrj.com.cn/2018/05/24182524586684.shtml",
    "datetime": "2018-05-24 18:25:50",
    "code": "600566"
  },
  {
    "title": "济川药业：关于实施权益分派时“济川转债”转股连续停牌的提示性公告",
    "href": "http://stock.jrj.com.cn/2018/05/18234124561745.shtml",
    "datetime": "2018-05-18 23:41:28",
    "code": "600566"
  },
  {
    "title": "济川药业：蒲地蓝消炎口服液等药品纳入安徽医保目录",
    "href": "http://stock.jrj.com.cn/hotstock/2018/05/17075924551543.shtml",
    "datetime": "2018-05-17 07:59:58",
    "code": "600566"
  },
  {
    "title": "济川药业蒲地蓝消炎口服液等药品纳入安徽医保目录",
    "href": "http://stock.jrj.com.cn/2018/05/16202024549945.shtml",
    "datetime": "2018-05-16 20:20:22",
    "code": "600566"
  },
  {
    "title": "济川药业：2017年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2018/05/11221024529243.shtml",
    "datetime": "2018-05-11 22:10:02",
    "code": "600566"
  },
  {
    "title": "济川药业：健胃消食口服液进入江苏省医保目录",
    "href": "http://stock.jrj.com.cn/2018/04/23180024434899.shtml",
    "datetime": "2018-04-23 18:00:00",
    "code": "600566"
  },
  {
    "title": "济川药业：一季度净利4.67亿元 同比增60%",
    "href": "http://stock.jrj.com.cn/hotstock/2018/04/23075924430723.shtml",
    "datetime": "2018-04-23 07:59:56",
    "code": "600566"
  },
  {
    "title": "济川药业：年报净利同比增30.97% 拟10派10元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/04/23075924430769.shtml",
    "datetime": "2018-04-23 07:59:56",
    "code": "600566"
  },
  {
    "title": "济川药业：2018年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/21001024425688.shtml",
    "datetime": "2018-04-21 00:10:39",
    "code": "600566"
  },
  {
    "title": "济川药业：关于召开2017年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2018/04/21001024425689.shtml",
    "datetime": "2018-04-21 00:10:39",
    "code": "600566"
  },
  {
    "title": "济川药业：第八届董事会第十一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/04/21001024425687.shtml",
    "datetime": "2018-04-21 00:10:38",
    "code": "600566"
  },
  {
    "title": "济川药业：2017年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/04/21001024425686.shtml",
    "datetime": "2018-04-21 00:10:36",
    "code": "600566"
  },
  {
    "title": "济川药业：拟10派10元 一季度净利同比增60%",
    "href": "http://stock.jrj.com.cn/2018/04/20190024424521.shtml",
    "datetime": "2018-04-20 19:00:00",
    "code": "600566"
  },
  {
    "title": "济川药业：2017年实现净利润12.23亿元 同比增长30.97%",
    "href": "http://stock.jrj.com.cn/2018/04/20185724424593.shtml",
    "datetime": "2018-04-20 18:57:00",
    "code": "600566"
  },
  {
    "title": "济川药业年报净利增长三成 拟10派10元",
    "href": "http://stock.jrj.com.cn/2018/04/20180724424138.shtml",
    "datetime": "2018-04-20 18:07:03",
    "code": "600566"
  },
  {
    "title": "济川药业：未来业绩有望继续保持较快增长",
    "href": "http://stock.jrj.com.cn/2018/02/28144324168539.shtml",
    "datetime": "2018-02-28 14:43:00",
    "code": "600566"
  },
  {
    "title": "济川药业：遭控股股东的一致行动人清仓减持2.65%股份",
    "href": "http://stock.jrj.com.cn/2018/02/27184024162056.shtml",
    "datetime": "2018-02-27 18:40:00",
    "code": "600566"
  },
  {
    "title": "济川药业：第八届董事会第九次会议决议公告",
    "href": "http://stock.jrj.com.cn/2017/11/27224023703493.shtml",
    "datetime": "2017-11-27 22:40:00",
    "code": "600566"
  },
  {
    "title": "济川药业：子公司蒲地蓝消炎口服液进入青海省医保目录",
    "href": "http://stock.jrj.com.cn/2017/10/20195523264238.shtml",
    "datetime": "2017-10-20 19:55:00",
    "code": "600566"
  },
  {
    "title": "济川药业：关于召开2017年第三次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2017/10/16222023241000.shtml",
    "datetime": "2017-10-16 22:20:00",
    "code": "600566"
  },
  {
    "title": "济川药业公开发行可转换公司债券获证监会批复",
    "href": "http://stock.jrj.com.cn/2017/10/11181523216860.shtml",
    "datetime": "2017-10-11 18:15:24",
    "code": "600566"
  },
  {
    "title": "济川药业：2017年第二次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2017/05/25224022535300.shtml",
    "datetime": "2017-05-25 22:40:03",
    "code": "600566"
  },
  {
    "title": "济川药业：实际控制人增持对公司构成利好",
    "href": "http://stock.jrj.com.cn/2016/03/23233520731220.shtml",
    "datetime": "2016-03-23 23:35:48",
    "code": "600566"
  },
  {
    "title": "济川药业年报拟10派7元 净利增长32%",
    "href": "http://stock.jrj.com.cn/2016/03/18205120711383.shtml",
    "datetime": "2016-03-18 20:51:40",
    "code": "600566"
  },
  {
    "title": "济川药业2015年净利同比增长32.03%",
    "href": "http://stock.jrj.com.cn/2016/02/24201320603862.shtml",
    "datetime": "2016-02-24 20:13:32",
    "code": "600566"
  },
  {
    "title": "济川药业业绩增长稳健",
    "href": "http://stock.jrj.com.cn/2015/05/11165419208405.shtml",
    "datetime": "2015-05-11 16:54:14",
    "code": "600566"
  },
  {
    "title": "洪城股份：拟以2.8亿元购买银行理财产品",
    "href": "http://stock.jrj.com.cn/hotstock/2014/12/02075918455596.shtml",
    "datetime": "2014-12-02 07:59:56",
    "code": "600566"
  },
  {
    "title": "洪城股份56亿并购临阵少要5亿 资产狸猫换太子",
    "href": "http://stock.jrj.com.cn/2014/10/06144018118619.shtml",
    "datetime": "2014-10-06 14:40:25",
    "code": "600566"
  },
  {
    "title": "洪城股份收入高增长具确定性 给予公司“买入”评级",
    "href": "http://stock.jrj.com.cn/2014/09/19001118037878.shtml",
    "datetime": "2014-09-19 00:11:22",
    "code": "600566"
  },
  {
    "title": "再降6.48亿 洪城股份募资额缩水六成",
    "href": "http://stock.jrj.com.cn/2013/12/03085516263255.shtml",
    "datetime": "2013-12-03 08:55:48",
    "code": "600566"
  },
  {
    "title": "洪城股份重组获审核通过 明起复牌",
    "href": "http://stock.jrj.com.cn/2013/11/20190716186835.shtml",
    "datetime": "2013-11-20 19:07:00",
    "code": "600566"
  },
  {
    "title": "洪城股份遭荆州市国资委减持",
    "href": "http://stock.jrj.com.cn/2013/09/12161715832017.shtml",
    "datetime": "2013-09-12 16:17:00",
    "code": "600566"
  },
  {
    "title": "洪城股份涨逾6% 重组方案获股东大会通过",
    "href": "http://stock.jrj.com.cn/invest/2013/08/21093715716522.shtml",
    "datetime": "2013-08-21 09:37:00",
    "code": "600566"
  },
  {
    "title": "洪城股份复牌后4涨停 重组方案20日能否通过悬念大",
    "href": "http://stock.jrj.com.cn/2013/08/13154215674894.shtml",
    "datetime": "2013-08-13 15:42:26",
    "code": "600566"
  },
  {
    "title": "52股连涨超五日 洪城股份6天涨近八成",
    "href": "http://stock.jrj.com.cn/hotstock/2013/08/12183715668818.shtml",
    "datetime": "2013-08-12 18:37:22",
    "code": "600566"
  },
  {
    "title": "洪城股份演绎“妖股”本色",
    "href": "http://stock.jrj.com.cn/2013/08/10085815662162.shtml",
    "datetime": "2013-08-10 08:58:44",
    "code": "600566"
  },
  {
    "title": "本周十大牛股解析：洪城股份变身药企周涨逾61%",
    "href": "http://stock.jrj.com.cn/hotstock/2013/08/09173015661326.shtml",
    "datetime": "2013-08-09 17:30:49",
    "code": "600566"
  },
  {
    "title": "快讯：洪城股份8月8日涨停",
    "href": "http://stock.jrj.com.cn/invest/2013/08/08093715652603.shtml",
    "datetime": "2013-08-08 09:37:38",
    "code": "600566"
  },
  {
    "title": "收购美国WAL油田资产 美都控股17天翻倍",
    "href": "http://stock.jrj.com.cn/2013/08/06112915639784.shtml",
    "datetime": "2013-08-06 11:29:13",
    "code": "600566"
  },
  {
    "title": "快讯：洪城股份8月6日涨停",
    "href": "http://stock.jrj.com.cn/invest/2013/08/06093815639005.shtml",
    "datetime": "2013-08-06 09:38:53",
    "code": "600566"
  },
  {
    "title": "快讯：济川药业56亿资产借壳 洪城股份复牌涨停",
    "href": "http://stock.jrj.com.cn/invest/2013/08/05094315632460.shtml",
    "datetime": "2013-08-05 09:43:57",
    "code": "600566"
  },
  {
    "title": "快讯：洪城股份8月5日涨停",
    "href": "http://stock.jrj.com.cn/invest/2013/08/05093215632334.shtml",
    "datetime": "2013-08-05 09:32:54",
    "code": "600566"
  },
  {
    "title": "济川控股借壳洪城股份 置入济川药业100%股权",
    "href": "http://stock.jrj.com.cn/2013/07/10190715510924.shtml",
    "datetime": "2013-07-10 19:07:20",
    "code": "600566"
  },
  {
    "title": "洪城股份龙虎榜数据一览(5/25)",
    "href": "http://stock.jrj.com.cn/hotstock/2012/05/25183513269976.shtml",
    "datetime": "2012-05-25 18:35:39",
    "code": "600566"
  },
  {
    "title": "洪城股份拟6000万售铸造部资产",
    "href": "http://stock.jrj.com.cn/2011/12/12200811812463.shtml",
    "datetime": "2011-12-12 20:08:49",
    "code": "600566"
  },
  {
    "title": "洪城股份5日起停牌 讨论重大资产处置问题",
    "href": "http://stock.jrj.com.cn/2011/12/05214711727233.shtml",
    "datetime": "2011-12-05 21:47:46",
    "code": "600566"
  },
  {
    "title": "广东游资助推洪城股份6连阳",
    "href": "http://stock.jrj.com.cn/hotstock/2011/09/22002711106604.shtml",
    "datetime": "2011-09-22 00:27:08",
    "code": "600566"
  }
]